The glucose dependent insulinotropic polypeptide response to oral glucose and mixed meals is increased in patients with Type 2 (non-insulin-dependent) diabetes mellitus
Authors:
- 1 September 1989
- journal article
- research article
- Published by Springer Nature in Diabetologia
- Vol. 32 (9) , 668-677
Abstract
Considerable disagreement exists regarding the levels of immunoreactive glucose dependent insulinotropic polypeptide in patients with Type 2 (non-insulin-dependent) diabetes mellitus. Glucose dependent insulinotropic polypeptide levels were therefore studied during oral glucose and mixed meal tolerance tests in normal subjects (n=31) and newly presenting previously untreated patients with Type 2 diabetes mellitus (n=68). The tests were performed in random order after overnight fasts and blood samples were taken at 30 min intervals for 4 h. During the oral glucose tolerance test plasma glucose dependent insulinotropic polypeptide levels increased in the normal subjects from a fasting value of 20±3 pmol/l to a peak of 68±5 pmol/l at 30 min and in the Type 2 diabetic patients from a similar fasting level of 27±3 pmol/l to a higher peak value of 104±6 pmol/l at 30 min (ppppp<0.05) during the meal tolerance test. The groups were subdivided on the basis of degree of obesity and glucose dependent insulinotropic polypeptide concentrations were still higher in the diabetic subgroups compared with the normal subjects matched for weight. Type 2 diabetes mellitus is associated with an exaggerated glucose dependent insulinotropic polypeptide response to oral glucose and mixed meals which is independent of any effect of obesity.Keywords
This publication has 28 references indexed in Scilit:
- The effects of glucose-dependent insulinotropic polypeptide infused at physiological concentrations in normal subjects and Type 2 (non-insulin-dependent) diabetic patients on glucose tolerance and B-cell secretionDiabetologia, 1987
- The heterogeneity of gastric inhibitory polypeptide in porcine and human gastrointestinal mucosa evaluated with five different antiseraRegulatory Peptides, 1984
- The isolation and sequencing of human gastric inhibitory peptide (GIP)FEBS Letters, 1984
- Fasting and postprandial plasma GIP values in man measured with seven different antiseraRegulatory Peptides, 1983
- A RADIOIMMUNOASSAY OF GASTRIC INHIBITORY POLYPEPTIDE IN HUMAN PLASMAJournal of Endocrinology, 1980
- The incretin concept todayDiabetologia, 1979
- Gastric inhibitory polypeptide (GIP) and insulin in obesity: Increased response to stimulation and defective feedback control of serum levelsDiabetologia, 1978
- Radioimmunological determination of human C-peptide in serumDiabetologia, 1975
- Release of immunoreactive gastric inhibitory polypeptide (IR-GIP) by oral ingestion of food substancesThe American Journal of Surgery, 1975
- Determination of total serum insulin (IRI) in insulin-treated diabetic patientsDiabetologia, 1972